Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

The reduction in the number of fractions in radiotherapy is especially attractive in several senses, and even more so considering breast cancer, which has a high incidence and generally favorable prognosis. Thus, as a reference Institution, the investigators intend to start the treatment of selected patients with a radiotherapy scheme of 26 Gy / 5 fractions in one week, in a controlled manner, through this project.The investigators consider the moment extremely propitious to start the study, as in addition to having the first publication of a large randomized study, proving the effectiveness a

Trial Details

NCT ID

NCT05665920

Phase

NA

Sponsor

Instituto Brasileiro de Controle do Cancer

Status

RECRUITING

Cancer Type

Breast Cancer

Interventions

• Ultra-hypofractionated whole breast radiotherapy
• Standard Radiation

Locations (sample)

• São Paulo, São Paulo, Brazil|-23.5475,-46.63611

Key Eligibility Criteria

• Information to the patient and signed informed consent;
• Women aged ≥18 years;
• Breast conserving surgery;
• Invasive adenocarcinoma (except classic invasive lobular carcinoma);

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →